Elisabetta C.
- Country
- Italy
- Department
- UOC EMATOLOGIA E TRAPIANTO DI CELLULE STAMINALI
Research Overview
- Prospective Study on Nilotinib Versus Imatinib with Nilotinib Switch in BCR-ABL+ Chronic Myeloid Leukemia in Chronic Phase
- Long-term Evaluation of Givinostat in JAK2V617F Positive Chronic Myeloproliferative Neoplasms: Safety, Tolerability, and Efficacy Analysis
- Randomized, open-label, multicenter phase 3 study to assess the efficacy and safety of GIVinostat versus hydroxyurea IN JAK2V617F-positive high-risk Polycythemia Vera patients: the GIV-IN PV TRIAL
Data & Insights
Has run more than one trial at 18 of 90 partner sites.
Specializations
Hematologic Malignancies
This investigator specializes in treating various myeloproliferative disorders, with particular emphasis on conditions affecting blood cell production and bone marrow function.
- Chronic Myeloproliferative Neoplasms (cMPN)
- Chronic Myeloid Leukemia (CML)
- Polycythemia Vera
The investigator focuses on novel therapeutic approaches for these conditions, particularly in managing chronic phase manifestations.
Molecular Targeted Therapies
Expertise in treating blood disorders characterized by specific genetic mutations, particularly focusing on JAK2V617F-positive conditions and BCR-ABL positive leukemias.
- Tyrosine Kinase Inhibitor Therapy
- JAK2 Targeted Treatments
- Novel Therapeutic Agents
The investigator evaluates innovative treatment approaches for patients with specific genetic mutations in blood disorders.
Treatment Optimization
Specializes in developing and evaluating long-term treatment strategies for chronic hematologic conditions, with focus on improving patient outcomes and quality of life.
- Treatment Response Assessment
- Disease Management Strategies
- Therapeutic Drug Monitoring
The investigator explores optimal treatment approaches for patients with chronic blood disorders requiring extended therapy.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.